COMP <GO>
SRPT vs SLS // REVENUE GROWTH (YOY)
Sarepta Therapeutics Inc. (NASDAQ) VS. SELLAS Life Sciences Group Inc. (NASDAQ) • 15-METRIC TALLY: SRPT 2
— SLS 3
■ METRIC PARITY
LAST: $19.23 (-0.47%) • MKT CAP: $2.03B
revenue-growth
4.30%
LAST: $10.15 (-2.17%) • MKT CAP: $2.05B
revenue-growth
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SRPT VS. SLS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SRPT | SLS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 96.00% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -21.80% | -13.20 | SLS | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -15.14% | -1.38% | -13.76 | SLS | /fcf-yield <GO> |
| Operating Margin | -37.50% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | -38.30% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | 4.30% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 0.20 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | SRPT | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.2 | 38.7 | +12.55 | SRPT | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.03B | $2.05B | -$19.6M | SLS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SRPT REV | SLS REV | SRPT GROSS % | SLS GROSS % | SRPT FCF | SLS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.86B | $0 | 98.0% | — | -$307.5M | -$28.4M |
| FY 2024 | $1.79B | $0 | — | — | -$342.7M | -$35.4M |
| FY 2023 | $1.14B | $0 | — | — | -$501.0M | -$31.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SRPT // BETA —
SLS // BETA —